2022 M&A Healthcare Advisors Transactional Outlook Part Two: Pharmacy
M&A Healthcare Advisors has released the second video in its Transactional Outlook series. In the most recent video, company Partner & Executive Advisor Andre Ulloa focuses on four types of pharmacy. Ulloa provided the firm’s 2022 outlook for specialty, community retail, long-term care and infusion pharmacy. “Specialty pharmacy valuations have remained stable in recent years…
This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.
Get featured
Want MarketScale to feature Healthcare?
Book a 15-minute demo and we'll map your Healthcare expertise to the content buyers are searching for.
M&A Healthcare Advisors has released the second video in its Transactional Outlook series. In the most recent video, company Partner & Executive Advisor Andre Ulloa focuses on four types of pharmacy.
Ulloa provided the firm’s 2022 outlook for specialty, community retail, long-term care and infusion pharmacy.
“Specialty pharmacy valuations have remained stable in recent years in spite of downward pressure on sales, gross margin and net income,” Ulloa said.
While certain segments of the pharmacy market remain strong, not all of them have fared as well recently.
“Long-term care pharmacies have experienced one of the steepest valuation declines in recent years as a result of COVID and home-based care,” Ulloa noted.
For more insight into the healthcare business market, follow the latest from M&A Healthcare Advisors here.
Your experts belong here
Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.
Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.
